{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:24:32Z","timestamp":1785266672002,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","amjmedsci.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.amjms.2024.08.029","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T19:34:33Z","timestamp":1727292873000},"page":"346-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The expression and clinical significance of cytokines Th1, Th2, and Th17 in ovarian cancer"],"prefix":"10.1016","volume":"369","author":[{"given":"Chibo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingtang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2024.08.029_bib0001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bpobgyn.2020.02.010","article-title":"Ovarian cancer screening: current status and future directions","volume":"65","author":"Nash","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.amjms.2024.08.029_bib0002","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-319-23730-5_8","article-title":"microRNA and ovarian cancer","volume":"889","author":"Langhe","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.amjms.2024.08.029_bib0003","first-page":"m3773","article-title":"Treatment of epithelial ovarian cancer","volume":"371","author":"Kuroki","year":"2020","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.amjms.2024.08.029_bib0004","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.029_bib0005","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ygyno.2017.01.015","article-title":"Single cell reveals heterogeneity withoutovarian cancer epithelium andcancer associated stromal cell","volume":"144","author":"Winterhoff","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.amjms.2024.08.029_bib0006","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.amjms.2024.08.029_bib0007","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/1354750X.2020.1783574","article-title":"Serum cytokines and CXCR2: potential tumour markers in ovarian neoplasms","volume":"25","author":"Micheli","year":"2020","journal-title":"Biomarkers"},{"issue":"7","key":"10.1016\/j.amjms.2024.08.029_bib0008","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00262-020-02831-1","article-title":"Immunologic factors involved in the malignant transformation of endometriosis to endometriosis-associated ovarian carcinoma","volume":"70","author":"Leenen","year":"2021","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"10.1016\/j.amjms.2024.08.029_bib0009","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone I Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.029_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000010312","article-title":"Analysis of TH1 and TH2 cells by intracellular cytokine detection with flow cytometry in patients with ovarian cancer","volume":"50","author":"Aoki","year":"2000","journal-title":"Gynecol Obstet Invest"},{"issue":"7","key":"10.1016\/j.amjms.2024.08.029_bib0011","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3390\/cells9071721","article-title":"Engineering CD4+ T cells to enhance cancer immunity","volume":"9","author":"Sillito","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.amjms.2024.08.029_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8797683","article-title":"Th17 Cells and IL-17 as novel immune targets in ovarian cancer therapy","volume":"2020","author":"Bilska","year":"2020","journal-title":"J Oncol"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.029_bib0013","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000010312","article-title":"Analysis of TH1 and TH2 cells by intracellular cytokine detection with flow cytometry in patients with ovarian cancer","volume":"50","author":"Aoki","year":"2000","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"10.1016\/j.amjms.2024.08.029_bib0014","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7150\/ijms.47384","article-title":"Circulating Th22 cells, as well as Th17 cells, are elevated in patients with renal cell carcinoma","volume":"18","author":"Peng","year":"2021","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1016\/j.amjms.2024.08.029_bib0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10552-022-01639-x","article-title":"Circulating IL-10 is associated with reduced risk of prostate cancer in a prospective cohort of elderly men: the MrOS Study","volume":"34","author":"Thomas","year":"2023","journal-title":"Cancer Causes Control"},{"issue":"9","key":"10.1016\/j.amjms.2024.08.029_bib0016","doi-asserted-by":"crossref","first-page":"e23947","DOI":"10.1002\/jcla.23947","article-title":"The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis","volume":"35","author":"Chen","year":"2021","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"10.1016\/j.amjms.2024.08.029_bib0017","first-page":"370","article-title":"Potential role of preoperative serum CA12 for the differential diagnosis between uterine leiomyoma and uterine leimyosarcoma","volume":"27","author":"Juang","year":"2006","journal-title":"Eur J Gynaecol Oncol"},{"issue":"25","key":"10.1016\/j.amjms.2024.08.029_bib0018","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R","article-title":"Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer","volume":"73","author":"Plante","year":"1994","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.amjms.2024.08.029_bib0019","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0002-9378(91)90582-C","article-title":"Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer","volume":"164","author":"Berek","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.029_bib0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1165\/rcmb.2009-0440OC","article-title":"Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury","volume":"44","author":"Hoegl","year":"2011","journal-title":"Am J Resp Cell Mol"},{"issue":"2","key":"10.1016\/j.amjms.2024.08.029_bib0021","first-page":"187","article-title":"The increased ratio of Treg\/Th2 in promoting metastasis of hepatocellular carcinoma","volume":"90","author":"Li","year":"2022","journal-title":"Cir Cir"},{"issue":"2","key":"10.1016\/j.amjms.2024.08.029_bib0022","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(03)00002-9","article-title":"Interleukin-17 family and IL-17 receptors","volume":"14","author":"Moseley","year":"2003","journal-title":"Cytokine growth factor rev"},{"key":"10.1016\/j.amjms.2024.08.029_bib0023","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1038\/onc.2010.367","article-title":"Up for Mischief IL-17\/Th17 in the tumor micro- environment","volume":"29","author":"Maniati","year":"2010","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.amjms.2024.08.029_bib0024","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00262-010-0849-6","article-title":"Th17 cells: positive or negative role in tumor","volume":"59","author":"Ji","year":"2010","journal-title":"Cancer Immunol Immun"},{"key":"10.1016\/j.amjms.2024.08.029_bib0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1743-422X-9-232","article-title":"Increased expressions of IL-22 and Th22 cells in thecoxsackievirus B3-Induced mice acute viral myocarditis","volume":"9","author":"Kong","year":"2012","journal-title":"Virol J"},{"issue":"7","key":"10.1016\/j.amjms.2024.08.029_bib0026","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12272-019-01146-9","article-title":"T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer","volume":"42","author":"Chang","year":"2019","journal-title":"Arch Pharm Res"},{"issue":"6","key":"10.1016\/j.amjms.2024.08.029_bib0027","first-page":"561","article-title":"Ovarian cancer: an overview","volume":"91","author":"Penny","year":"2020","journal-title":"Radiol Technol"},{"issue":"1","key":"10.1016\/j.amjms.2024.08.029_bib0028","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12032-013-0808-0","article-title":"HE4 combined with CA125: favorable screening tool for ovarian","volume":"31","author":"Ghasemi","year":"2014","journal-title":"Cancer Med Oncol"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.029_bib0029","first-page":"375","article-title":"Proinflammatory and immuno- suppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors","volume":"31","author":"Nowak","year":"2010","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.amjms.2024.08.029_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.669474","article-title":"Differentiation and regulation of th cells: a balancing act for cancer immunotherapy","volume":"12","author":"Basu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjms.2024.08.029_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.632581","article-title":"Metabolic interdependency of Th2 cell- mediated type 2 immunity and the tumor microenvironment","volume":"12","author":"Schreiber","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.amjms.2024.08.029_bib0032","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12905-020-00972-0","article-title":"The disease stage-associated imbalance of Th1\/Th2 and Th17\/Treg in uterine cervical cancer patients and their recovery with the reduction of tumor burden","volume":"20","author":"Lin","year":"2020","journal-title":"BMC Womens Health"},{"issue":"2","key":"10.1016\/j.amjms.2024.08.029_bib0033","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15027936","article-title":"Effects of the balance between type 1 and type 2 T helper cells on ovarian cancer","volume":"15","author":"Hao","year":"2016","journal-title":"Genet Mol Res"},{"issue":"2","key":"10.1016\/j.amjms.2024.08.029_bib0034","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00405-015-3779-2","article-title":"Th1-, Th2-, and Th17-associated cytokine expression in hypopharyngeal carcinoma and clinical significance","volume":"273","author":"Chen","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"7","key":"10.1016\/j.amjms.2024.08.029_bib0035","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/1933719112466299","article-title":"Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer","volume":"20","author":"C\u00e2ndido","year":"2013","journal-title":"Reprod Sci"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924014794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924014794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T09:15:50Z","timestamp":1741943750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962924014794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0002962924014794"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2024.08.029","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The expression and clinical significance of cytokines Th1, Th2, and Th17 in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2024.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}